Droit CEO Brock Arnason Discusses Challenges of Reporting Rewrites

Regulators from the US, Europe and UK to Japan, Australia, Singapore and Hong Kong have been working on rule revisions to harmonise data requirements for OTC derivatives reporting – changes that present a significant burden to financial institutions.

Regulation Asia co-founder Nick Wakefield sat down with Brock Arnason, Founder and Chief Executive Officer at Droit, to discuss the alignment between different reporting regimes, the challenges for firms needing to accommodate the new requirements, and best practice recommendations for reporting architecture.

To Top
Share via
Copy link
Powered by Social Snap